Reporting Manager
Steven A. Cohen
Symbol
PRAX
Shares outstanding
20,973,123 shares
Disclosed Ownership
1,531,038 shares
Ownership
7.3%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 17:01:28 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
Next filing
14 Nov 2025

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 7.3% ownership in Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX) on 30 Jun 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX).
  • Disclosed ownership: 7.3%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Aug 2025, 17:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 7% 1,465,105 0 1,465,105 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 7% 1,465,105 0 1,465,105 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Biotech Private Investments, LLC 0.3% 65,933 0 65,933 /s/ Vincent Tortorella Vincent Tortorella, Authorized Person
Differentiated Ventures Investments, LLC 0.3% 65,933 0 65,933 /s/ Vincent Tortorella Vincent Tortorella, Authorized Person
72 Investment Holdings, LLC 0.3% 65,933 0 65,933 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 7.3% 1,531,038 0 1,531,038 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .